You are currently browsing the reports category
Displaying 25 - 30 of 166 entries.

A clinical-stage biopharmaceutical business with a focus on cardiovascular disease.

Amarin completes patient randomization in AMR101 Stage 3 trial in sufferers with high triglyceride levels Amarin Corporation plc , a clinical-stage biopharmaceutical business with a focus on cardiovascular disease, today reported the completion of patient randomization for its ANCHOR trial, a pivotal Phase 3 trial of AMR101. THE BUSINESS indicated that it anticipates reporting top-line results from this trial in Q2 2011 http://www.montfordpharmacy.com . The ANCHOR trial can be a multi-center, placebo-managed, randomized, double-blind, 12-week pivotal research to evaluate the efficacy and basic safety of 2 grams and 4 grams of AMR101 in sufferers with high triglyceride amounts from 200 mg/dL to less than 500 mg/dL who are also on statin therapy.

Are over-the-counter vision medications or drops effective for pink eye?

Are over-the-counter vision medications or drops effective for pink eye? Artificial tears are usually safe, and although they could not cure the pink attention, they often times somewhat help alleviate the symptoms. Ocular decongestants ought to be used just sparingly as they may mask the symptoms and in some cases worsen the problem by contributing to dryness or irritation. For allergic conjunctivitis, various kinds over-the-counter medications can be found and are generally very effective.

Lawmakers are weighing abortion expenses.

Ariz. Senate approves costs to ban state money for Planned Parenthood The vote follows abortion restrictions passed by the Arizona legislature this season tadalafilnorge.com . In addition, N.H., Calif. And La. Lawmakers are weighing abortion expenses. Arizona Republic: Planned Parenthood Funds At Risk In Arizona Arizona is normally on the verge of joining eight other states that have banned the usage of general public dollars for Planned Parenthood. The Senate on Tuesday approved a bill that would bar the condition or any nearby government from using public money to support an organization which includes abortions among its solutions.

Research American and co-author College of Gastroenterology President Douglas K.

Is usually available for interviews. Results of a fresh multicenter study by Cotton et al. Released today in the Journal of the American Medical Association evaluating standard colonoscopy with CT colonography for the detection of colorectal tumor reveal that technology, in the proper execution used most in the usa often, while of significant interest, isn’t a viable choice for routine colorectal cancers screening presently. The analysis utilized abdominal-pelvic CT scanning and the radiologists relied primarily on 2-dimensional pictures but 3-dimensional ‘fly-throughs’ of the colon that simulate standard colonoscopy had been also evaluated Related StoriesStudy shows vitamin D, supplements fail to drive back colorectal cancerResearchers find method to screen bloodstream samples to detect existence of precancerous polyps in the colonMayo Clinic cancer experts find gaps in current colorectal cancer tumor screening approachesThe study found that the sensitivity of CT colonography for detecting individuals with 1 or more lesions sized at least 6 mm was 39 %, and for lesions sized at least 10 mm it was 55 %, this weighed against 99 % and 100 % respectively when examined using standard colonoscopy generally known as complete colonoscopy.

Appropriate use criteria for coronary revascularization If youre committed to fitness.

Appropriate use criteria also present details in easily understood scientific scenarios that characterize sufferers according to four vital features: The severity and type of symptoms; Just how much cholesterol plaque has built up and in which arteries; Just how much of the center muscle, according to stress testing, is being starved for blood and oxygen ; and Whether the patient is already taking the proper heart medications in the right dosages. In developing the correct use criteria, a 17-member technical panel made up of general cardiologists, interventional cardiologists, cardiac surgeons, internal medicine specialists, health services researchers and others sifted through 180 clinical scenarios around, scoring each according to whether revascularization was appropriate, inappropriate or uncertain.

Announced that the U today.

Celator Pharmaceuticals’ CPX-351 receives FDA Fast Track designation for secondary AML treatment Celator Pharmaceuticals, Inc. , a biopharmaceutical company that is transforming the research of mixture therapy and developing products to improve patient outcomes in cancers, announced that the U today www.tadora.biz .S. Food and Medication Administration granted Fast Track designation for CPX-351 for the treatment of elderly individuals with secondary Acute Myeloid Leukemia . The FDA established the Fast Track designation process to facilitate the development and expedite the review of drugs designed to treat serious or life-threatening conditions and that demonstrate the potential to handle unmet medical needs.